America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Examines conditions under which index funds tend to outperform active options, with practical implications for portfolio building.
15,084 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
CrowdStrike stock absolutely hammered this week, yet the dip isn’t a clear buy signal. I break down the risks, the gr...
Gas prices in Illinois have jumped, putting the state near the top of the nation’s most expensive lists. This guide e...
As Zymeworks gears up for 2026 earnings, investors should focus on cash runway, pipeline milestones, and collaboratio...
A growing gap between what Social Security takes in and what it pays out could hit retirees hard. Learn who’s at risk...
As Silicon Valley confronted its latest liquidity scare, a circle of less-visible players stepped in to steady payrol...
Analysts say the United States holds roughly $45 trillion in natural resources, a cushion that could delay debt press...
Today’s market moved in Ford’s favor as analysts primed optimism around Ford’s energy initiatives alongside its tradi...
SpaceX is partnering with Anthropic to unlock massive AI compute at a Tennessee data center. This could reshape Anthr...
A legendary TV send-off isn’t just about drama. It exposes the hidden costs of chaos—how budgets, insurance, and risk...
Lawmakers and regulators weigh a $1.7 billion compensation fund to settle Trump’s suit with $1.7 against the IRS, a m...
Bitcoin prices declined as investors rotated toward safer assets, marking a negative week for digital asset funds. Ye...